Dong Qian , Xinyuan Luan, Yanan Zhang

The Third Department of Hepatobiliary and Pancreatic Diseases, Nankai Hospital, Tianjin 300100, China;

For correspondence:-  Dong Qian   Email: NKYYLXY@163.com

Accepted: 7 June 2022        Published: 30 November 2022

Citation: Qian D, Luan X, Zhang Y. Erratum: Effect of low molecular weight heparin and ulinastatin as a combined therapy on soluble myeloid cell expression and intestinal mucosal function in patients with severe pancreatitis. Trop J Pharm Res 2022; 21(11):2493-2493 doi: 10.4314/tjpr.v21i11.32

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Keywords: Heparin, ulinastatin, myeloid cell expression, intestinal mucosal function, severe pancreatitis

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)